Preoperative plasma vascular endothelial growth factor but not nitrite is a useful complementary tumor marker in patients with colorectal cancer

Diseases of the Colon and Rectum

Volumn 49, Issue 6, 2006, Pages 883-894

  Tsai, Wen Sy ^a   Changchien, Chung Rong ^a   Yeh, Chien Yuh ^a   Chen, Jinn Shiun ^a   Tang, Reiping ^a   Chiang, Jy Ming ^a   Hsieh, Pao Shiu ^a   Fan, Chung Wei ^a   Wang, Jeng Yi ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Colorectal cancer; Nitric oxide; Tumor marker; Vascular endothelial growth factor

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; NITRITE; TUMOR MARKER; VASCULOTROPIN;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER SURVIVAL; COLORECTAL CANCER; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENDER; HEMORRHOID; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOPATHOLOGY; HUMAN; LEUKOCYTOSIS; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; PREOPERATIVE PERIOD; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; STATISTICAL ANALYSIS; THROMBOCYTE COUNT; TUMOR LOCALIZATION; TUMOR VOLUME;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; NITRITES; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33744901724     PISSN: 00123706     EISSN: 15300358     Source Type: Journal    
DOI: 10.1007/s10350-006-0528-z     Document Type: Article

References (54)

1. D Hanahan J Folkman 1996 Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis Cell 86 353 364
2. J Rak Y Mitsuhashi L Bayko 1995 Mutant ras oncogenes upregulate VEGF/VPF expression: implications for induction and inhibition of tumor angiogenesis Cancer Res 55 4575 4580
3. LA Liotta PS Steeg WG Stetler-Stevenson 1991 Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation Cell 64 327 336
4. M Klagsbrun PA D'Amore 1996 Vascular endothelial growth factor and its receptors Cytokine Growth Factor Rev 7 259 270
5. N Ferrara T Davis Smyth 1997 The biology of vascular endothelial growth factor Endocr Rev 18 4 25
6. LE Brown B Berse RW Jakman 1993 Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of gastrointestinal tract Cancer Res 53 4727 4735
7. D Shweiki A Itian D Stoffer 1992 Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis Nature 359 843 845
8. AP Levy NS Levy S Wegner 1995 Transcriptional regulation of the rat vascular endothelial growth factors gene by hypoxia J Biol Chem 270 13333 13340
9. Y Shizukuda S Tang R Yokota 1999 Vascular endothelial growth factor-induced endothelial cell migration and proliferation depend on a nitric oxide-mediated decrease in protein kinase Cdelta activity Circ Res 85 247 256
10. S Moncada RM Palmer EA Higgs 1991 Nitric oxide: physiology, pathophysiology, and pharmacology Pharmacol Rev 43 109 142
11. WW Stark K Wasserloos R Modzelewski 1995 Hypoxia stimulate NFκB mediated iNOS expression in tumor endothelial cells Mol Biol Cell 6 438
12. MA Moro J De-Alba JC Leza 1998 Neuronal expression of inducible nitric oxide synthase after oxygen and glucose deprivation in rat forebrain slices Eur J Neurosci 10 445 456
13. GM Tozer SA Everett 1997 Nitric oxide in tumor biology and cancer therapy. Part I: physiologic aspects Clin Oncol 9 282 293
14. GM Tozer SA Everett 1997 Nitric oxide in tumor biology and cancer therapy. Part I: therapeutic implications Clin Oncol 9 357 364
15. N Weidner P Sample W Welch 1991 Tumor angiogenesis and metastases: correlation in invasive breast carcinoma N Engl J Med 324 1 8
16. Y Takahashi H Sasaki SJ Kim 1994 Markedly increased amount of messenger RNAs for vascular endothelial growth factor and placental growth factor in renal cell carcinoma associated with angiogenesis Cancer Res 54 4233 4237
17. K Maeda Y Chung Y Ogawa 1996 Prognostic value of vascular endothelial growth factor expression in gastric carcinoma Cancer 77 858 863
18. O Gallo E Masini L Mobedelli 1998 Role of nitric oxide in angiogenesis and tumor progression in head and neck cancer J Natl Cancer Inst 90 587 596
19. S Ambs WG Merriam WP Bennett 1998 Frequent nitric oxide synthase-2 expression in human colon adenomas: implication for tumor angiogenesis and colon cancer progression Cancer Res 58 334 341
20. RM Shaheen DW Davis W Liu 1999 Antiangiogenic therapy targeting the tyrosine kinase receptor for vascular endothelial growth factor receptor inhibits the growth of colon cancer liver metastasis and induces tumor and endothelial cell apoptosis Cancer Res 59 5412 5416
21. A Orucevic PK Lala 1996 NG-nitro-L-arginine methyl ester, an inhibitor of nitric oxide synthesis ameliorates interleukin 2-induced capillary leakage and reduces tumor growth in adenocarcinoma-bearing mice Br J Cancer 73 189 196
22. LM Ellis W Liu 1995 Vascular endothelial growth factor (VEGF) expression and alternate splicing in non-metastatic and metastatic human colon cancer cell lines Proc Am Assoc Cancer Res 36 88
23. RS Warren H Yuan MR Matli 1995 Regulation of vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis J Clin Invest 95 1787 1797
24. LE Brown B Berse RW Jakman 1993 Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of gastrointestinal tract Cancer Res 53 4727 4735
25. Y Takahashi CD Bucana KR Cleary 1998 p53, vessel count, and vascular endothelial growth factor expression in human colon cancer Int J Cancer 79 34 38
26. Y Takahashi SL Tucker Y Kitadai 1997 Vessel counts and VEGF expression as prognostic factors in node-negative colon cancer Arch Surg 132 541 546
27. SI Isigami S Arri M Furutani 1998 Predictive value of vascular endothelial growth factor (VEGF) in metastasis and prognosis of human colorectal cancer Br J Cancer 78 1379 1384
28. Y Yamamoto M Toi S Kondo 1996 Concentration of vascular endothelial growth factor in the sera of normal controls and cancer patients Clin Cancer Res 2 821 826
29. H Kumar K Heer PW Lee 1998 Preoperative serum vascular endothelial growth factor can predict stage in colorectal cancer Clin Cancer Res 4 1279 1285
30. KF Chin J Greenman E Gardiner 2000 Pre-operative serum vascular endothelial growth factor can select patients for adjuvant treatments after curative resection in colorectal cancer Br J Cancer 83 1425 1431
31. A Eroǧlu S Demirci A Ayyildiz 1999 Serum concentrations of vascular endothelial growth factor and nitrite as an estimate of in vivo nitric oxide in patients with gastric cancer Br J Cancer 80 1630 1634
32. HM Verheul K Hoekman S Luykx-de Bakker 1997 Platelet: transporter of vascular endothelial growth factors Clin Cancer Res 3 2187 2190
33. RE Banks MA Forbes SE Kinsey 1998 Release of angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biology Br J Cancer 77 956 964
34. NJ Webb MJ Bottomely CJ Watson 1998 Vascular endothelial growth factor (VEGF) is released from platelets during blood clotting: implications for measurement of circulating VEGF levels in clinical disease Clin Sci (Colch) 94 395 404
35. R Möhle D Green MA Moore 1997 Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets Proc Natl Acad Sci USA 94 663 668
36. W Jelkmann 2001 Pitfalls in the measurement of circulating vascular endothelial growth factor Clin Chem 47 617 623
37. MR Freeman FX Schneck ML Gagnon 1995 Peripheral blood T lymphocytes and lymphocytes infiltrating human cancers express vascular endothelial growth factor: a potential role for T cells angiogenesis Cancer Res 55 4140 4145
38. U Wartiovaara P Salven H Mikkola 1998 Peripheral blood platelets express VEGF-C and VEGF which are released during platelet activation Thromb Haemost 80 171 175
39. American Joint Commission on Cancer 1992 Manual for staging of cancer JB Lippincott Philadelphia
40. JE Park GA Keller N Ferrara 1993 The vascular endothelial growth factor (VEGF) isoforms: Differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF Mol Biol Cell 4 1317 1326
41. C Neufeld T Cohen S Gengrinovitch 1999 Vascular endothelial growth factor (VEGF) and its receptors FASEB J 13 9 22
42. RT Poon ST Fan J Wong 2001 Clinical implication of circulating angiogenic factors in cancer patients J Clin Oncol 19 1207 1225
43. W Wynendaele R Derua MF Hoylaerts 1999 Vascular endothelial growth factor measured in platelet poor plasma allows optimal separation between cancer patients and volunteers: a key to study an angiogenic marker in vivo? Ann Oncol 10 965 971
44. MM Davies SK Jonas S Kaur 2000 Plasma vascular endothelial but not fibroblast growth factor levels correlate with colorectal liver metastasis vascularity and volume Br J Cancer 82 1004 1008
45. Y Yonemura Y Endo H Fujita 1999 Role of vascular endothelial growth factor C expression in the development of lymph node metastasis in gastric cancer Clin Cancer Res 5 1823 1829
46. MJ Duffy 2001 Carcinoembryonic antigen as a marker for colorectal cancer: is it clinically useful? Clin Chem 47 624 630
47. HJ Wanebo B Rao CM Pinsky 1978 The use of preoperative carcinoembryonic antigen level as a prognostic indicator to complement pathologic staging N Engl J Med 299 448 451
48. LY Dirix PB Vermeulen A Pawinski 1997 Elevated levels of the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in sera of cancer patients Br J Cancer 76 238 243
49. K Werther IJ Christensen HJ Nielsen 2002 Prognostic impact of matched preoperative plasma and serum VEGF in patients with primary colorectal carcinoma Br J Cancer 86 417 423
50. MK Oehler H Caffier 2000 Prognostic relevance of serum vascular endothelial growth factor in ovarian cancer Anticancer Res 20 5109 5112
51. CO Mcdonnell JH Harmey DJ Bouchier-Hayes 2001 Effect of multimodality therapy on circulating vascular endothelial growth factor levels in patients with esophageal cancer Br J Surg 88 1105 1109
52. K Werther S Sorensen LJ Christensen 2003 Circulating vascular endothelial growth factor six months after primary surgery as a prognostic marker in patients with colorectal cancer Acta Oncol (Madr) 42 837 845
53. P Salven A Orpana H Joensuu 1999 Leukocytes and platelets of patients with cancer contain high levels of vascular endothelial growth factor Clin Cancer Res 5 487 491
54. ML George SA Eccles MG Totton 2000 Correlation of plasma and serum vascular endothelial growth factors levels with platelet count in colorectal cancer: clinical evidence of platelet scavenging? Clin Cancer Res 6 3147 3152